BELFOR, the Global Market Leader in Damage Restoration, Expands its Geographical Coverage With SSG Group, Scandinavia
22.6.2022 17:59:00 EEST | Business Wire | Press release
BELFOR, the world’s leading provider of disaster recovery services, and SSG, the Scandinavian market leader in damage restoration services, have joined forces to strengthen their customer service in Denmark, Sweden and Norway.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220622005595/en/
BELFOR, the Global Market Leader in Damage Restoration, Expands its Geographical Coverage With SSG Group, Scandinavia (Graphic: Business Wire)
BELFOR, now with more than 12.500 employees in 500+ locations throughout the world, covers the whole value chain in disaster recovery - from damage assessment, first mitigation measures, restoration to reconstruction services for small, large and technically complex losses.
SSG Group provides a broad service offering focussing on damage prevention, damage restoration, repair and reconstruction services with 980 employees in 57 locations in Denmark, Sweden and Norway.
“With SSG, we will grow our skilled and experienced teams with great people, increase our service capability and optimize our response times for our national and international clients”, explains Elvir Kolak, CEO of BELFOR Europe.
Carsten Fensholt, CEO of SSG Group, adds: "This transaction means a tremendous boost for our organizations in Denmark, Norway and Sweden as it adds the technical competence of BELFOR to our service portfolio and provides new development opportunities for our employees.”
BELFOR will now be the number 1 restoration company in Denmark supported by 650 people. This acquisition represents a significant step forward in terms of BELFOR’s geographical expansion into Scandinavia, which has started in Denmark in 2016 with the acquisition of Rosva followed by Rolund in 2021.
"We are happy to welcome SSG to our BELFOR family and are excited to support their future growth. SSG employs wonderful people with a great customer focus - a perfect match! We are proud to have them on board. Our growth plans are ambitious and we are looking for more great companies to join the BELFOR family - in Scandinavia as well as across Europe”, concludes Sheldon Yellen, the global CEO of BELFOR.
ABOUT BELFOR
BELFOR is the world's leading provider of disaster recovery services. BELFOR has over 40 years of experience, covering the whole value chain from damage assessment, restoration and renovation services. This makes us a preferred partner for the insurance industry as well as for commercial and private clients.
With SSG, BELFOR will have more than 12,500 employees and 500+ locations in 57 countries. Ready to help customers on small, large and technically complex losses 24/7, 365 days a year.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220622005595/en/
Contact information
Cornelia Meyer von Bremen
Tel: +49 (0) 203 - 7 56 40-300
cornelia.meyervonbremen@belfor.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 15:00:00 EEST | Press release
Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-making. However, compared to Riskified’s agentic commerce pulse survey in Q4 2025, consumer sentiment has shifted, with growing concerns around fraud, security, and accountability slowing the path to fully autonomous, agent-driven transactions. Key findings from th
Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 15:00:00 EEST | Press release
Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environment. The findings highlight a growing disconnect between ambition and execution. Cross-border transactions are expected to form a significant portion of deal pipelines, with 47% of respondents expecting them to account for between 26% and
Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼ REZZAYO ® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 14:43:00 EEST | Press release
Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing allogeneic HSCT face prolonged periods of immunosuppression and routinely require extended antifungal prophylaxis,1 representing a setting where differentiated dosing, improved side effect profile, and reduced DDI is beneficial, and comparable efficacy is expected. The ReSPECT study met its primary endpoint for US Food and Drug Administration (FDA) and European Medicines
tesa Selects Kinaxis as the Digital Backbone for Global Integrated Business Planning Transformation27.4.2026 14:00:00 EEST | Press release
Kinaxis® (TSX: KXS), a global leader in end‑to‑end supply chain orchestration, today announced that tesa SE, a global manufacturer of adhesive tapes and self-adhesive product solutions, has selected the Kinaxis Maestro™ platform as a core enabler of its global, multi‑year supply chain and integrated business planning (IBP) transformation. Following an extensive evaluation, tesa selected Kinaxis to support its evolution from regionally fragmented planning practices toward a centrally governed, globally orchestrated IBP operatingmodel. Kinaxis will support tesa in improving enterprise-wide transparency, strengthening resilience, and enabling faster, more informed decision making across an increasingly complex and volatile global supply chain network. With 130 years of innovation, tesa is one of the world’s leading manufacturers of adhesive tapes and self-adhesive product solutions. Operating across six global regions and serving both complex industrial and fast-moving consumer markets, t
vVARDIS Announces Investment from Apollo —Achieves Unicorn Status27.4.2026 14:00:00 EEST | Press release
vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415938477/en/ Photo credit: Jos Schmid, Photographer vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulations clinically proven to treat tooth decay. Curodont™ supports en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom